Ambu Future Growth
Future criteria checks 4/6
Ambu is forecast to grow earnings and revenue by 27% and 10.2% per annum respectively. EPS is expected to grow by 27% per annum. Return on equity is forecast to be 14.8% in 3 years.
Key information
27.0%
Earnings growth rate
27.0%
EPS growth rate
Medical Equipment earnings growth | 14.2% |
Revenue growth rate | 10.2% |
Future return on equity | 14.8% |
Analyst coverage | Good |
Last updated | 28 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2027 | 7,609 | 1,041 | 870 | 1,338 | 5 |
9/30/2026 | 6,769 | 807 | 635 | 1,046 | 7 |
9/30/2025 | 6,034 | 630 | 453 | 839 | 7 |
9/30/2024 | 5,391 | 235 | 524 | 813 | N/A |
6/30/2024 | 5,263 | 450 | 614 | 893 | N/A |
3/31/2024 | 5,075 | 367 | 608 | 902 | N/A |
12/31/2023 | 4,897 | 238 | 501 | 805 | N/A |
9/30/2023 | 4,775 | 168 | 192 | 518 | N/A |
6/30/2023 | 4,679 | -42 | -168 | 217 | N/A |
3/31/2023 | 4,612 | -65 | -318 | 119 | N/A |
12/31/2022 | 4,545 | 95 | -475 | 25 | N/A |
9/30/2022 | 4,444 | 93 | -463 | 95 | N/A |
6/30/2022 | 4,307 | 222 | -401 | 185 | N/A |
3/31/2022 | 4,152 | 256 | -521 | 107 | N/A |
12/31/2021 | 4,031 | 176 | -419 | 194 | N/A |
9/30/2021 | 4,013 | 247 | -256 | 328 | N/A |
6/30/2021 | 3,858 | 251 | -187 | 347 | N/A |
3/31/2021 | 3,832 | 281 | 111 | 593 | N/A |
12/31/2020 | 3,820 | 290 | 56 | 511 | N/A |
9/30/2020 | 3,567 | 241 | -135 | 295 | N/A |
6/30/2020 | 3,302 | 146 | -24 | 366 | N/A |
3/31/2020 | 3,128 | 270 | -62 | 277 | N/A |
12/31/2019 | 2,924 | 296 | 37 | 330 | N/A |
9/30/2019 | 2,820 | 317 | 272 | 533 | N/A |
6/30/2019 | 2,943 | 515 | 361 | 597 | N/A |
3/31/2019 | 2,843 | 411 | 316 | 553 | N/A |
12/31/2018 | 2,709 | 372 | 327 | 560 | N/A |
9/30/2018 | 2,606 | 337 | 318 | 554 | N/A |
6/30/2018 | 2,506 | 318 | N/A | 498 | N/A |
3/31/2018 | 2,434 | 288 | N/A | 456 | N/A |
12/31/2017 | 2,396 | 281 | N/A | 476 | N/A |
9/30/2017 | 2,355 | 301 | N/A | 462 | N/A |
6/30/2017 | 2,299 | 306 | N/A | 403 | N/A |
3/31/2017 | 2,215 | 299 | N/A | 460 | N/A |
12/31/2016 | 2,134 | 267 | N/A | 420 | N/A |
9/30/2016 | 2,084 | 250 | N/A | 369 | N/A |
6/30/2016 | 2,047 | 224 | N/A | 408 | N/A |
3/31/2016 | 2,012 | 169 | N/A | 269 | N/A |
12/31/2015 | 1,963 | 175 | N/A | 246 | N/A |
9/30/2015 | 1,889 | 152 | N/A | 208 | N/A |
6/30/2015 | 1,795 | 171 | N/A | 141 | N/A |
3/31/2015 | 1,710 | 184 | N/A | 137 | N/A |
12/31/2014 | 1,630 | 156 | N/A | 147 | N/A |
9/30/2014 | 1,584 | 151 | N/A | 183 | N/A |
6/30/2014 | 1,543 | 94 | N/A | 167 | N/A |
3/31/2014 | 1,524 | 67 | N/A | 141 | N/A |
12/31/2013 | 1,456 | 40 | N/A | 148 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 547A's forecast earnings growth (27% per year) is above the savings rate (1%).
Earnings vs Market: 547A's earnings (27% per year) are forecast to grow faster than the German market (20.9% per year).
High Growth Earnings: 547A's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 547A's revenue (10.2% per year) is forecast to grow faster than the German market (5.7% per year).
High Growth Revenue: 547A's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 547A's Return on Equity is forecast to be low in 3 years time (14.8%).